Sacubitril/Valsartan Decreases Cardiac Fibrosis in Left Ventricle Pressure Overload by Restoring PKG Signaling in Cardiac Fibroblasts
出版年份 2019 全文链接
标题
Sacubitril/Valsartan Decreases Cardiac Fibrosis in Left Ventricle Pressure Overload by Restoring PKG Signaling in Cardiac Fibroblasts
作者
关键词
-
出版物
Circulation-Heart Failure
Volume 12, Issue 4, Pages -
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2019-04-10
DOI
10.1161/circheartfailure.118.005565
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Resident fibroblast expansion during cardiac growth and remodeling
- (2018) Malina J. Ivey et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Small proline-rich protein 2B drives stress-dependent p53 degradation and fibroblast proliferation in heart failure
- (2018) Ryan M. Burke et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- LCZ696, an angiotensin receptor-neprilysin inhibitor, improves cardiac function with the attenuation of fibrosis in heart failure with reduced ejection fraction in streptozotocin-induced diabetic mice
- (2016) Yasunori Suematsu et al. EUROPEAN JOURNAL OF HEART FAILURE
- Genetic lineage tracing defines myofibroblast origin and function in the injured heart
- (2016) Onur Kanisicak et al. Nature Communications
- Pre-treatment with LCZ696, an orally active angiotensin receptor neprilysin inhibitor, prevents ischemic brain damage
- (2015) Hui-Yu Bai et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Thioredoxin-Interacting Protein Is a Biomechanical Regulator of Src Activity
- (2014) Oded N. Spindel et al. CIRCULATION RESEARCH
- Myocardin-related transcription factors control the motility of epicardium-derived cells and the maturation of coronary vessels
- (2014) M. A. Trembley et al. DEVELOPMENT
- Efficacy and Safety of LCZ696, a First-in-Class Angiotensin Receptor Neprilysin Inhibitor, in Asian Patients With Hypertension
- (2014) Kazuomi Kario et al. HYPERTENSION
- Resident fibroblast lineages mediate pressure overload–induced cardiac fibrosis
- (2014) Thomas Moore-Morris et al. JOURNAL OF CLINICAL INVESTIGATION
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Guanylyl cyclase/natriuretic peptide receptor-A signaling antagonizes phosphoinositide hydrolysis, Ca2+ release, and activation of protein kinase C
- (2014) Kailash N. Pandey Frontiers in Molecular Neuroscience
- Mechanisms of fibrosis: therapeutic translation for fibrotic disease
- (2012) Thomas A Wynn et al. NATURE MEDICINE
- The Actin–MRTF–SRF Gene Regulatory Axis and Myofibroblast Differentiation
- (2012) Eric M. Small Journal of Cardiovascular Translational Research
- Guanylyl cyclase / atrial natriuretic peptide receptor-A: role in the pathophysiology of cardiovascular regulation
- (2011) Kailash N. Pandey CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Heart Disease and Stroke Statistics—2009 Update
- (2009) et al. CIRCULATION
- Differential VASP phosphorylation controls remodeling of the actin cytoskeleton
- (2009) P. M. Benz et al. JOURNAL OF CELL SCIENCE
- Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual-Acting Angiotensin Receptor-Neprilysin Inhibitor (ARNi)
- (2009) Jessie Gu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Regulation of natriuretic peptide receptor-A gene expression and stimulation of its guanylate cyclase activity by transcription factor Ets-1
- (2008) Prerna Kumar et al. BIOSCIENCE REPORTS
- Cardiac Plasticity
- (2008) Joseph A. Hill et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started